Evaluation of p16 immunostaining to predict high-grade cervical intraepithelial neoplasia in women with Pap results of atypical squamous cells of undetermined significance

Diagnostic Cytopathology

Volumn 39, Issue 7, 2011, Pages 482-488

  Guo, Ming ^a   Warriage, Irfan ^b   Mutyala, Bramara ^a   Patel, Shobha ^a   Lin, E ^a   Gong, Yun ^a   Sneige, Nour ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER SCHOOL OF MEDICINE   (United States)

Author keywords

ASC US; genotyping; HPV; human papillomavirus; p16; SurePath

Indexed keywords

PROTEIN P16; VIRUS DNA;

ADULT; AGED; ARTICLE; CANCER GRADING; CONTROLLED STUDY; FEMALE; GENOTYPE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PAPANICOLAOU TEST; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SQUAMOUS CELL; UTERINE CERVIX BIOPSY; UTERINE CERVIX CARCINOMA IN SITU; WART VIRUS;

CERVICAL INTRAEPITHELIAL NEOPLASIA; FEMALE; GENOTYPE; HUMANS; NEOPLASM PROTEINS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PRECANCEROUS CONDITIONS; PREDICTIVE VALUE OF TESTS; TUMOR MARKERS, BIOLOGICAL; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 79959595403     PISSN: 87551039     EISSN: 10970339     Source Type: Journal    
DOI: 10.1002/dc.21415     Document Type: Article

References (33)

1. Klaes R, Friedrich T, Spitkovsky D, et al. Overexpression of p16(INK4A) as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri. Int J Cancer 2001; 92: 276-284. (Pubitemid 32225381)
2. Sano T, Masuda N, Oyama T, Nakajima T,. Overexpression of p16 and p14ARF is associated with human papillomavirus infection in cervical squamous cell carcinoma and dysplasia. Pathol Int 2002; 52 (5-6): 375-383. (Pubitemid 34748220)
3. Nieh S, Chen SF, Chu TY, Lai HC, Fu E,. Expression of p16 INK4A in Papanicolaou smears containing atypical squamous cells of undetermined significance from the uterine cervix. Gynecol Oncol 2003; 91: 201-208. (Pubitemid 37188612)
4. Yoshida T, Fukuda T, Sano T, Kanuma T, Owada N, Nakajima T,. Usefulness of liquid-based cytology specimens for the immunocytochemical study of p16 expression and human papillomavirus testing: A comparative study using simultaneously sampled histology materials. Cancer 2004; 102: 100-108. (Pubitemid 38489967)
5. Guo M, Hu L, Baliga M, He Z, Hughson MD,. The predictive value of p16(INK4a) and hybrid capture 2 human papillomavirus testing for high-grade cervical intraepithelial neoplasia. Am J Clin Pathol 2004; 122: 894-901. (Pubitemid 39577357)
6. Holladay EB, Logan S, Arnold J, Knesel B, Smith GD,. A comparison of the clinical utility of p16(INK4a) immunolocalization with the presence of human papillomavirus by hybrid capture 2 for the detection of cervical dysplasia/neoplasia. Cancer 2006; 108: 451-461. (Pubitemid 46076964)
7. Carozzi F, Cecchini S, Confortini M, et al. Role of P16(INK4a) expression in identifying CIN2 or more severe lesions among HPV-positive patients referred for colposcopy after abnormal cytology. Cancer 2006; 108: 119-123.
8. Meyer JL, Hanlon DW, Andersen BT, Rasmussen OF, Bisgaard K,. Evaluation of p16INK4a expression in ThinPrep cervical specimens with the CINtec p16INK4a assay: Correlation with biopsy follow-up results. Cancer 2007; 111: 83-92. (Pubitemid 46648406)
9. Monsonego J, Pollini G, Evrard MJ, et al. P16(INK4a) immunocytochemistry in liquid-based cytology samples in equivocal Pap smears: Added value in management of women with equivocal Pap smear. Acta Cytol 2007; 51: 755-766. (Pubitemid 47443610)
10. Duncan L, Jacob S, Hubbard E,. Evaluation of p16INK4a as a diagnostic tool in the triage of Pap smears demonstrating atypical squamous cells of undetermined significance. Cancer 2008; 114: 34-48. (Pubitemid 351304611)
11. Schledermann D, Andersen BT, Bisgaard K, et al. Are adjunctive markers useful in routine cervical cancer screening? Application of p16(INK4a) and HPV-PCR on ThinPrep samples with histological follow-up. Diagn Cytopathol 2008; 36: 453-459. (Pubitemid 351897370)
12. Shin EK, Lee SR, Kim MK, et al. Immunocytochemical staining of p16(ink4a) protein as an adjunct test in equivocal liquid-based cytology. Diagn Cytopathol 2008; 36: 311-316.
13. Benevolo M, Vocaturo A, Mottolese M, et al. Clinical role of p16INK4a expression in liquid-based cervical cytology: Correlation with HPV testing and histologic diagnosis. Am J Clin Pathol 2008; 129: 606-612. (Pubitemid 352029280)
14. Nassar A, O'Reilly K, Cohen C, Siddiqui MT,. Comparison of p16INK4A and hybrid capture 2 human papillomavirus testing as adjunctive tests in liquid-based gynecologic SurePath preparations. Diagn Cytopathol 2008; 36: 142-148. (Pubitemid 351312127)
15. Sano T, Oyama T, Kashiwabara K, Fukuda T, Nakajima T,. Expression status of p16 protein is associated with human papillomavirus oncogenic potential in cervical and genital lesions. Am J Pathol 1998; 153: 1741-1748. (Pubitemid 28550662)
16. Agoff SN, Lin P, Morihara J, Mao C, Kiviat NB, Koutsky LA,. p16(INK4a) expression correlates with degree of cervical neoplasia: A comparison with Ki-67 expression and detection of high-risk HPV types. Mod Pathol 2003; 16: 665-673. (Pubitemid 36871499)
17. Hu L, Guo M, He Z, Thornton J, McDaniel LS, Hughson MD,. Human papillomavirus genotyping and p16INK4a expression in cervical intraepithelial neoplasia of adolescents. Mod Pathol 2005; 18: 267-273. (Pubitemid 40188635)
18. Kong CS, Balzer BL, Troxell ML, Patterson BK, Longacre TA,. p16INK4A immunohistochemistry is superior to HPV in situ hybridization for the detection of high-risk HPV in atypical squamous metaplasia. Am J Surg Pathol 2007; 31: 33-43. (Pubitemid 46036900)
19. Murphy N, Ring M, Killalea AG, et al. p16INK4A as a marker for cervical dyskaryosis: CIN and cGIN in cervical biopsies and ThinPrep smears. J Clin Pathol 2003; 56: 56-63. (Pubitemid 36132476)
20. Tsoumpou I, Arbyn M, Kyrgiou M, et al. p16(INK4a) immunostaining in cytological and histological specimens from the uterine cervix: A systematic review and meta-analysis. Cancer Treat Rev 2009; 35: 210-220.
21. Wright TC, Jr, Massad LS, Dunton CJ, Spitzer M, Wilkinson EJ, Solomon D,. 2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests. Am J Obstet Gynecol 2007; 197: 346-355. (Pubitemid 47464164)
22. Solomon D, Davey D, Kurman R, et al. The 2001 Bethesda System: Terminology for reporting results of cervical cytology. JAMA 2002; 287: 2114-2119. (Pubitemid 34437346)
23. Trunk MJ, Dallenbach-Hellweg G, Ridder R, et al. Morphologic characteristics of p16INK4a-positive cells in cervical cytology samples. Acta Cytol 2004; 48: 771-782. (Pubitemid 39518255)
24. Wentzensen N, Bergeron C, Cas F, Eschenbach D, Vinokurova S, von Knebel Doeberitz M,. Evaluation of a nuclear score for p16INK4a-stained cervical squamous cells in liquid-based cytology samples. Cancer 2005; 105: 461-467. (Pubitemid 43067004)
25. Lin CY, Chen HC, Lin RW, et al. Quality assurance of genotyping array for detection and typing of human papillomavirus. J Virol Methods 2007; 140 (1-2): 1-9.
26. Huang LW, Chao SL, Chen PH, Chou HP,. Multiple HPV genotypes in cervical carcinomas: Improved DNA detection and typing in archival tissues. J Clin Virol 2004; 29: 271-276.
27. Stoler MH, Schiffman M,. Interobserver reproducibility of cervical cytologic and histologic interpretations: Realistic estimates from the ASCUS-LSIL Triage Study. JAMA 2001; 285: 1500-1505. (Pubitemid 32221899)
28. Solomon D, Schiffman M, Tarone R,. Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: Baseline results from a randomized trial. J Natl Cancer Inst 2001; 93: 293-299. (Pubitemid 32219816)
29. Sahebali S, Depuydt CE, Segers K, et al. P16INK4a as an adjunct marker in liquid-based cervical cytology. Int J Cancer 2004; 108: 871-876. (Pubitemid 38112616)
30. Samama B, Schaeffer C, Boehm N,. P16 expression in relation to human papillomavirus in liquid-based cervical smears. Gynecol Oncol 2008; 109: 285-290.
31. Bose S, Evans H, Lantzy L, Scharre K, Youssef E,. p16(INK4A) is a surrogate biomarker for a subset of human papilloma virus-associated dysplasias of the uterine cervix as determined on the Pap smear. Diagn Cytopathol 2005; 32: 21-24. (Pubitemid 40024069)
32. Guo M, Patel SJ, Chovanec M, et al. A human papillomavirus testing system in women with abnormal Pap results: A comparison study with follow-up biopsies. Acta Cytol 2007; 51: 749-754. (Pubitemid 47443609)
33. Mao C, Balasubramanian A, Yu M, et al. Evaluation of a new p16(INK4A) ELISA test and a high-risk HPV DNA test for cervical cancer screening: Results from proof-of-concept study. Int J Cancer 2007; 120: 2435-2438. (Pubitemid 46642131)